Institutional Ownership
Alnylam Pharmaceuticals Inc
CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ1 2026
Consensus
Buy
As of Jul 1, 2026
Analysts
38
Covering this month
Buy
76%
29 of 38
Sell
0%
0 of 38
Recommendation Distribution
Current month · 38 analysts
Strong Buy
8
Buy
21
Hold
9
Sell
0
Strong Sell
0
Recommendation Trend
Monthly analyst breakdown
| Month | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | 8 | 21 | 9 | 0 | 0 | Buy |
| Jun 1, 2026 | 7 | 21 | 9 | 0 | 0 | Buy |
| May 1, 2026 | 7 | 20 | 9 | 0 | 0 | Buy |
| Apr 1, 2026 | 7 | 20 | 9 | 0 | 0 | Buy |
| Mar 1, 2026 | 8 | 20 | 8 | 0 | 0 | Buy |